NeuroOne Medical Technologies Corporation NMTC recently received FDA 510(k) clearance for its OneRF Trigeminal Nerve Ablation ...

"NeuroOne’s nerve ablation system secures FDA clearance" was originally created and published by Medical Device Network, a ...

Trigeminal nerve ablation, a minimally invasive procedure, uses RF energy to destroy abnormal tissue and relieve severe, ...

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical ...

FDA clearance of the OneRF device for trigeminal neuralgia marks the company’s first expansion into the treatment of chronic pain. NeuroOne also sells its FDA-cleared OneRF sEEG brain ablation system ...

The OneRF™ Ablation System is NeuroOne’s first device with a therapeutic indication and its third FDA 510 (k)-cleared device. NeuroOne now boasts a full line of thin film electrode technology ...

Ronald W. McClurg, CFO, said, "product revenue increased 105% to $1.7 million" and cited "sizable improvements year-over-year ...

NeuroOne Medical Technologies(NASDAQ:NMTC) reported fiscal third quarter 2025 earnings on August 14, 2025, with product revenue up 105% year-over-year to $1.7 million and product gross margins rising ...

Published Dec 6, 2022 9:00am EST Animal study completed under the guidance of Dr. Jamie Van Gompel at the Mayo Clinic in Rochester, MN Company on track to submit OneRF 510 (k) application to the ...

NeuroOne® OneRF® Technology Success Story Featured on Fox News Provided by GlobeNewswire Apr 14, 2025 6:00am ...

Discover insights from NeuroOne Medical Technologies (NMTC)'s Q3 2025 earnings call, featuring 105% revenue growth, new clinical milestones, and ...

Detailed price information for Neuroone Medical Technologies Corp (NMTC-Q) from The Globe and Mail including charting and trades.